Round voting button logo

H.R.1492

To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.

Introduced·2/21/25

Equalizes negotiation period for small-molecule and biologic drugs under the Drug Price Negotiation Program.

The bill amends title XI of the Social Security Act to extend the negotiation period for biologic drugs to match that of small-molecule drugs under the Drug Price Negotiation Program. The change sets the negotiation period to 11 years, aligning it with small-molecule drugs. The amendment will take effect as if included in the enactment of Public Law 117–169.

Included in complete analysis

  • Overview
  • Core Provisions
  • Implementation
  • Impact
  • Legal Framework
  • Critical Issues

See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.

Where it stands

Current
Energy And Commerce Committee
Next
Committee decision

Sponsors

DDDD
4
65
RRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRR
Democratic CaucusRepublican Caucus

History

Feb 21, 2025

House

Introduced in House

Feb 21, 2025

House

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.